SCHEMBL2488084

SCHEMBL2488084

CCCCC(C(=O)OCl)c1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASP1 P29466 1/20 0.45
CYP3A4 P08684 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CA2 P00918 1/20 0.40
HPGD P15428 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GBA1 P04062 1/20 0.38
CTSK P43235 1/20 0.38
RAB9A P51151 1/20 0.38
SAE1 Q9UBE0 1/20 0.38
UBA2 Q9UBT2 1/20 0.38
KCNQ2 O43526 1/20 0.38
HTT P42858 1/20 0.38
LMNA P02545 1/20 0.37
TSHR P16473 2/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11852028 0.88 CASP1 (0.45) CASP1CYP3A4ALDH1A1CA2HPGD
SCHEMBL27518364 0.86 HPGD (0.44) CASP1CYP3A4ALDH1A1CA2HPGD
SCHEMBL11862712 0.84 CASP1 (0.44) CASP1CYP3A4HPGDMEN1KMT2A
SCHEMBL10895395 0.83 MEN1 (0.46) CASP1ALDH1A1HPGDMEN1KMT2A
SCHEMBL11853455 0.83 PPARG (0.45) CASP1CYP3A4ALDH1A1HPGDLMNA
SCHEMBL11861787 0.83 PPARG (0.45) CASP1CYP3A4ALDH1A1HPGDLMNA
SCHEMBL11854678 0.83 PPARG (0.45) CASP1CYP3A4ALDH1A1HPGDLMNA
SCHEMBL11857168 0.79 CASP1 (0.47) CASP1ALDH1A1NPSR1KCNQ2HTT
SCHEMBL1133620 0.78 CYSLTR2 (0.44) CASP1ALDH1A1HPGDMEN1KMT2A
SCHEMBL27508354 0.78 CYSLTR2 (0.44) CASP1ALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379553-A1 BICYCLIC COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION Bristol-Myers Squibb Company (US) 2011-10-26 EP disclosed
WO-2010083141-A1 BICYCLIC COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-22 WO disclosed